Sudden Hearing Loss in One Ear: Why It Happens and Why It Can’t Wait

In over two decades of audiology practice, I’ve had patients describe hearing loss in almost every way imaginable. But there’s a particular kind of story that still stops me — the ones that start with “I woke up and something was just… off.” One ear quiet. Not ringing, not aching. Just gone. No warning, no obvious cause, nothing dramatic the night before. By the time these patients find their way to my chair at Audiology Island, days have often already passed. Sometimes more than a week. And that, more than the hearing loss itself, is what concerns me most.

What they’re describing is sudden sensorineural hearing loss — and it is a medical emergency.

Clinically, we define it as a drop of at least 30 decibels across three or more adjacent audiometric frequencies, occurring within 72 hours [1]. According to the NIDCD, more than 66,000 Americans experience this every year, though the real figure is likely higher — too many people chalk it up to earwax or a blocked eustachian tube and never see a specialist [2]. That delay is where hearing is permanently lost. It’s something I’ve seen happen in our Staten Island community more times than I’d like to count, and it’s exactly why I’m writing this.

Quick Reference:

Sudden hearing loss — clinically known as SSNHL or sudden deafness — is an unexplained drop of 30 dB or more in hearing ability, typically in one ear, developing within 72 hours. In roughly 90% of cases, no definitive cause is identified. The most likely mechanisms involve viral infection, a disrupted blood supply to the cochlea, or an autoimmune response targeting inner ear tissue. Corticosteroid treatment must begin within 10–14 days of onset; after that window closes, recovery becomes unlikely. If you or a family member notices sudden hearing change, reach out to an audiologist immediately — you’re welcome to contact me or my colleague Dr. Zhanneta Shapiro at Audiology Island.

Medical Context: What Is Actually Happening Inside the Ear?

The Cochlea Under Siege

I often explain the cochlea to patients this way: picture a tiny, spiraling concert hall — fluid-filled, lined with thousands of hair cells so delicate they can detect vibrations measured in nanometers. Sound enters, the fluid moves, the hair cells fire electrical signals along the auditory nerve, and the brain makes sense of it all in milliseconds. The whole system depends on a precise biological balance — stable blood flow, a clean chemical environment, no viral interference, and an immune system that knows to leave well enough alone.

Disrupt any one of those conditions, and the concert hall goes dark. Fast.

Early in my career, when I was working as a research assistant on an FDA grant study, I developed real respect for how little we can actually see inside a living cochlea. The inner ear is encased in the hardest bone in the human body — it’s virtually impossible to biopsy or observe directly during an acute event. That’s why, even today, over 90% of SSNHL cases are labeled idiopathic, meaning the cause cannot be identified despite a full workup [3]. Order the MRI, pull the blood panels, run comprehensive audiometry — and still, in roughly 99 out of 100 cases, no smoking gun [4]. Researchers work from inference, from animal models, from who recovers and who doesn’t. Three theories have survived that process most convincingly.

Viral Infection: The Leading Suspect

One of the first questions I ask a new SSNHL patient is whether they’d been sick recently. Not dramatically sick — just a mild cold, a bit of congestion, something they barely thought about two or three weeks ago [5]. The answer, a striking number of times, is yes. And that matters, because viruses like herpes simplex, HIV, mumps, rubella, and a range of enteroviruses have all been identified as potential cochlear aggressors — reaching the inner ear via the bloodstream or cerebrospinal fluid and either directly destroying hair cells or igniting the kind of inflammatory cascade that finishes the job secondhand. I’ve written more about this on our site: our piece on viral causes of hearing loss covers which pathogens are most implicated and how they get there [6].

The experimental case for herpes simplex is probably the strongest. HSV-infected animal models showed outer hair cell loss, scarring of the scala tympani, and stria vascularis atrophy — findings nearly identical to those in human temporal bones from patients with confirmed infection-related hearing loss [6]. Whether the virus kills cells directly or simply provokes an inflammatory response that does it remains debated. COVID-19 has added a new wrinkle to this whole picture: preliminary evidence suggests SARS-CoV-2 can involve the cochlea, though whether its mechanism mirrors classical viral SSNHL or follows a distinct vascular-inflammatory path still isn’t settled.

Vascular Disruption: The Flow Problem

Here’s something that surprises many of my patients when I explain it: the cochlea has exactly one artery feeding it. One. The labyrinthine artery supplies the entire inner ear with no collateral circulation, no backup route — nothing [4]. A microclot, a vasospasm, anything that cuts off that single supply line, and ischemia begins almost immediately.

What makes this hypothesis compelling isn’t anatomy alone — it’s what the outcomes data show. During my years working alongside ENT specialists at one of the largest otolaryngology groups in New York, I saw firsthand how badly patients with systemic vascular disease fared after SSNHL. The research matches that experience precisely: in one cohort, diabetic patients recovered at just 14.3%. Those with hypertension showed zero recovery — not a single patient [7]. Compare that to an overall recovery rate of 62.5% in healthier cohorts. That collapse in outcomes isn’t a statistical artifact. It’s the vascular model telling us something real.

Autoimmune Attack: The Inner Ear as a Target

The cochlea is supposed to be immunologically protected — what researchers call a privileged site, shielded from the body’s inflammatory machinery. But that privilege isn’t guaranteed. In conditions like Cogan’s syndrome, lupus, or autoimmune inner ear disease, the immune system turns on cochlear structures directly, producing hearing loss that can strike fast, hit hard, and sometimes affect both ears [8]. There’s also an underappreciated connection I frequently discuss with patients: thyroid disease and sensorineural hearing loss share overlapping autoimmune pathways that our field is taking increasingly seriously.

Bilateral SSNHL — affecting both ears simultaneously — occurs in only 4–17% of cases [2]. When it does, autoimmune etiology moves to the front of my differential. Not because it’s the most common explanation, but because it’s the most testable one, and the one that’s most often overlooked when clinicians aren’t actively looking for it.

Clinical Picture: Recognizing the Condition

Symptoms That Demand Immediate Attention

My patients describe this experience in different words, but the shape of the story is almost always the same. One woman told me it felt like someone had quietly stuffed wet cotton into her right ear while she slept. A man in his 50s described picking up his phone that morning and noticing the voice had simply vanished on one side — mid-sentence, nothing. Some hear a sharp, startling pop just before the silence comes. Others don’t realize anything has changed until they close their “good” ear and find the other one has quietly stopped participating [2].

Tinnitus accompanies SSNHL in more than 90% of cases. Dizziness arrives in roughly 40% [9, 10]. That triad — abrupt unilateral hearing loss, ringing, and a sense of fullness or pressure — is the condition’s clinical signature. And yet it keeps getting dismissed, both by patients and, more worryingly, by clinicians who reach for “eustachian tube dysfunction” before considering anything more urgent. I’ll add one nuance worth knowing: if the ringing you’re experiencing pulses in time with your heartbeat, that’s a separate issue — pulsatile tinnitus — with its own distinct causes and evaluation path. Research shows the average lag between SSNHL onset and the start of treatment is 10.8 days [11]. Given everything I’m about to describe regarding the treatment window, that number should trouble you as much as it troubles me.

The Treatment Window: Why Every Day Matters

Ten to fourteen days. That is the window. After four weeks from symptom onset, the research is unambiguous: treatment is unlikely to change the outcome in any meaningful way [4, 12].

Corticosteroids — oral prednisolone or, when that proves insufficient, intratympanic dexamethasone injected directly through the eardrum — work by reducing cochlear inflammation and modulating whatever immune activity may be driving the damage. When given early to patients with mild-to-severe loss, steroid therapy produces recovery in approximately 75–80% of cases [13]. That figure falls to around 10% for profound loss of 100 dB or greater, even with prompt treatment [14]. The difference between those two outcomes often comes down to a single variable: how quickly the patient got in front of a specialist.

I understand the temptation to wait. Spontaneous recovery happens in 32–65% of cases without any intervention at all [9] — and when patients discover that statistic online, some decide to give it a few days and see. I can’t in good conscience recommend that approach. There is no test I can run, no audiogram I can read, that will tell me on day one whether you’re in the group that recovers naturally or the group that doesn’t. And the upper bound of that spontaneous recovery estimate almost certainly includes misdiagnosed cases. Waiting, in effect, means betting your hearing on odds you can’t actually calculate.

“When patients arrive describing sudden muffled hearing in one ear, the first thing I want to rule out is SSNHL — not earwax, not a blocked tube. Because if it is sudden sensorineural hearing loss and we wait even a week to investigate, that window is already partially closed. Time isn’t on our side with this diagnosis.”— Dr. Zhanneta Shapiro, Au.D., Co-founder, Audiology Island

Discussion: What the Numbers Don’t Fully Explain

I want to be honest with you about the recovery rate data, because I think patients deserve that honesty. The numbers floating around — 75–80% with treatment, 32–65% without — are real figures from real studies, but they come with considerable caveats. “Recovery” is defined differently across studies. Patient populations vary enormously. Follow-up periods are inconsistent. And the most fundamental problem: you cannot ethically run a placebo-controlled trial on a time-sensitive condition where withholding treatment might mean permanent deafness. What we have is largely retrospective, observational data. I use it clinically because it’s the best evidence available — not because it’s settled science.

Age matters, though perhaps not in the way people assume. Younger patients tend to recover better, but the explanation isn’t age itself — it’s cochlear reserve. Decades of hypertension, unmanaged cholesterol, noise exposure, and small vascular insults accumulate quietly in the inner ear long before any single acute event [2]. When SSNHL strikes an older cochlea, it’s often hitting a structure that was already working harder than it should have been. That connection between long-term hearing health and systemic disease is something I write about specifically in the context of hearing aids and dementia risk — the downstream consequences of untreated hearing loss go well beyond the ear itself.

Vertigo at onset is a consistent predictor of worse outcomes across multiple independent datasets [10]. My clinical interpretation: it signals broader inner ear involvement, not just a focal cochlear lesion. When both the cochlea and the vestibular system are disrupted simultaneously, the damage tends to be more extensive — and the prognosis reflects that.

As for COVID-19’s role, I remain cautiously curious. The case reports are real. The biological plausibility is there. But controlled population-level data are still thin, and I’m not yet comfortable advising clinicians to treat COVID-associated SSNHL differently from classical idiopathic cases without stronger evidence. The NIDCD’s resource page on sudden deafness is where I point both patients and colleagues for the most current, authoritative guidance.

Limitations Worth Acknowledging

The steroid evidence base is genuinely weaker than its widespread clinical adoption might suggest. Robust placebo-controlled trials essentially don’t exist for the ethical reasons I described. What we rely on is mechanistic reasoning, observational data, and a clinical consensus that formed when withholding treatment felt unconscionable. That’s not nothing — but it’s not the gold standard either. For clinicians who want a rigorous, up-to-date synthesis of the evidence, the American Speech-Language-Hearing Association (ASHA) maintains peer-reviewed clinical resources on SSNHL that reflect current best practice. All statistics in this article — recovery rates, incidence figures, prognostic variables — carry the inherent uncertainty of their source literature. I’ve tried to represent that uncertainty faithfully rather than smooth it away.

Conclusion

After more than two decades in this field — starting in research, moving through clinical practice alongside some of the best ENTs in New York, and eventually building Audiology Island from the ground up with Dr. Shapiro — the cases that stay with me longest are the ones that arrived too late. Patients who waited two weeks because they assumed it would resolve. Patients whose primary care doctors told them to come back in a month. People who had no idea that the clock was already running. Sudden sensorineural hearing loss is a condition that disguises urgency as inconvenience, and that disguise costs people their hearing every single year. The treatment window cannot wait. Two weeks separates a recoverable event from a permanent one — and that distance is not theoretical. I’ve seen it on both sides. If something feels wrong with your hearing today, please don’t rationalize it away. Call us, call your ENT, call someone. That call may be the most important one you make.

---

Frequently Asked Questions

Is sudden hearing loss in one ear a medical emergency?

Yes — and I say that not to alarm you, but because it’s true. Any unexplained, rapid shift in hearing, particularly in a single ear, warrants same-day or next-day evaluation by an ENT or audiologist. The treatment window begins closing the moment symptoms appear.

What does sudden hearing loss feel like?

Most of my patients describe it as a muffled, pressured sensation — like cotton stuffed deep in the ear, or sound arriving through a wall. Tinnitus almost always accompanies it, sometimes dizziness too. A sharp “pop” immediately before the silence is another common description.

Can sudden hearing loss resolve on its own?

It can — spontaneous recovery occurs in 32–65% of cases within the first one to two weeks. But since there’s no way to predict on day one whether you’re in that group, waiting without medical evaluation is a gamble I wouldn’t advise any patient to take.

What causes sudden hearing loss?

In over 90% of cases, no definitive cause is ever identified. When one is found, it tends to involve viral infection, a disruption to the cochlea’s blood supply, autoimmune activity targeting the inner ear, acoustic neuromas, or ototoxic medications.

Who is most at risk?

SSNHL most often affects adults in their late 40s to early 50s, though I’ve seen it in patients across a wide age range. Diabetes, high blood pressure, and elevated cholesterol all correlate with worse recovery — the cochlea pays a price for systemic vascular disease long before the acute event arrives.

How is sudden hearing loss diagnosed?

A pure-tone audiogram is the essential starting point — it needs to show at least 30 dB of loss across three adjacent frequencies to confirm the diagnosis. From there, blood work, MRI, and balance testing may follow, though most cases remain idiopathic even after a thorough workup.

What happens if treatment is delayed past the window?

After roughly four weeks, the chance of meaningful recovery drops sharply regardless of what’s attempted. When hearing loss becomes permanent, management shifts to amplification — hearing aids, bone-anchored systems, or CROS devices, depending on the degree of loss and which ear is affected.

---

Sources

1. “Sudden Deafness,” National Institute on Deafness and Other Communication Disorders (NIDCD), NIH. Accessed February 2025. Retrieved from: https://www.nidcd.nih.gov/health/sudden-deafness
2. Stachler, R.J. et al. “Clinical Practice Guideline: Sudden Hearing Loss.” Otolaryngology–Head and Neck Surgery, 2012. American Academy of Otolaryngology–HNS. Retrieved from: https://journals.sagepub.com/doi/10.1177/0194599812436449
3. Kuhn, M. et al. “Sudden Sensorineural Hearing Loss: A Review of Diagnosis, Treatment, and Prognosis.” Trends in Amplification, 2011. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/21606048/
4. Rauch, S.D. “Clinical Practice: Idiopathic Sudden Sensorineural Hearing Loss.” New England Journal of Medicine, 2008. Retrieved from: https://www.nejm.org/doi/full/10.1056/NEJMcp0802129
5. Van Dishoeck, H.A.E. & Bierman, T.A. “Sudden Perceptive Deafness and Viral Infection.” Annals of Otology, Rhinology & Laryngology, 1957.
6. Merchant, S.N. et al. “Pathology and Etiology of Idiopathic Sudden Sensorineural Hearing Loss.” Otology & Neurotology, 2005. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/16151345/
7. Ioannidis, J.P.A. et al. “Prognostic factors for sudden sensorineural hearing loss — analysis of 374 patients.” ORL: Journal for Oto-Rhino-Laryngology, 2007.
8. Bovo, R. et al. “Immune-mediated inner ear disease.” Acta Oto-Laryngologica, 2006. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/16641083/
9. Mattox, D.E. & Simmons, F.B. “Natural history of sudden sensorineural hearing loss.” Annals of Otology, Rhinology & Laryngology, 1977.
10. Fetterman, B.L. et al. “Prognostic indicators in sudden sensorineural hearing loss.” American Journal of Otology, 1996.
11. Chau, J.K. et al. “Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss.” The Laryngoscope, 2010. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/20058265/
12. Shaia, F.T. & Sheehy, J.L. “Sudden sensori-neural hearing impairment: A report of 1220 cases.” The Laryngoscope, 1976.
13. Wilson, W.R. et al. “The efficacy of steroids in the treatment of idiopathic sudden hearing loss.” Archives of Otolaryngology, 1980.
14. Byl, F.M. “Sudden hearing loss: Eight years’ experience and suggested prognostic table.” The Laryngoscope, 1984.